MicroRNA expression profiles associated with the metastatic ability of MDA-MB-231 breast cancer cells
Issued Date
2023-08-01
Resource Type
ISSN
17921074
eISSN
17921082
Scopus ID
2-s2.0-85165431721
Journal Title
Oncology Letters
Volume
26
Issue
2
Rights Holder(s)
SCOPUS
Bibliographic Citation
Oncology Letters Vol.26 No.2 (2023)
Suggested Citation
Phannasil P., Akekawatchai C., Jitrapakdee S. MicroRNA expression profiles associated with the metastatic ability of MDA-MB-231 breast cancer cells. Oncology Letters Vol.26 No.2 (2023). doi:10.3892/ol.2023.13926 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/88144
Title
MicroRNA expression profiles associated with the metastatic ability of MDA-MB-231 breast cancer cells
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Breast cancer is an important worldwide public health concern. The incidence rate of breast cancer increases every year. The primary cause of death is metastasis, a process by which cancer cells spread from a primary site to secondary organs. MicroRNAs (miRs/miRNAs) are small non-coding RNAs that control gene expression at the post-transcriptional level. Dysregulation of certain miRNAs is involved in carcinogenesis, cancer cell proliferation and metastasis. Therefore, the present study assessed miRNAs associated with breast cancer metastasis using two breast cancer cell lines, the low-metastatic MCF-7 and the highly metastatic MDA-MB-231. miRNA array analysis of both cell lines indicated that 46 miRNAs were differentially expressed when compared between the two cell lines. A total of 16 miRNAs were upregulated in MDA-MB-231 compared with MCF-7 cells, which suggested that their expression levels may be associated with the highly invasive phenotype of MDA-MB-231 cells. Among these miRNAs, miR-222-3p was selected for further study and its expres- sion was confirmed by reverse transcription-quantitative PCR (RT-qPCR). Under both non-adherent and adherent culture conditions, the expression levels of miR-222-3p in the MDA-MB-231 cell line were higher than those noted in the MCF-7 cell line under the same conditions. Suppression of endogenous miR-222-3p expression in MDA-MB-231 cells using a miR-222-3p inhibitor resulted in a 20-40% reduction in proliferation, and a ~30% reduction in migration, which suggested that the aggressive phenotype of MDA-MB-231 cells was partly regulated by miR-222-3p. Bioinformatic analysis of miR-222-3p using TargetScan 8.0, miRDB and PicTar identified 25 common mRNA targets, such as cyclin-dependent kinase inhibitor 1B, ADP-ribosylation factor 4, iroquois homeobox 5 and Bcl2 modifying factor. The results of the present study indicated that miR-222-3p was potentially associated with the proliferation and migra- tory ability of the MDA-MB-231 cell line.